Life Science Today
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs.
Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
Eli Lilly + Innovent Biologics, Agios, TC Biopharm, Blue Water Vaccines, Meihua
The PD1 that lost, biopharma earns FDA approval, and the Biotech market is cool not dead
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Eli Lilly + Innovent Biologics
Agios
TC Biopharm
Blue Water Vaccines
Meihua
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
Arcellx, Intellia + Rewrite, Navitor + Janssen, ViiV
Dragons over unicorns, to CRISPR and beyond, spin-out-and-sell, and expanded approvals.
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Arcellx
Intellia + Rewrite
Navitor + Janssen
ViiV
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
Genentech, Immunocore, Biogen, Eli Lilly, TenSixteen
Bispecific antibodies, ocular oncology, Biogen sells, Lilly Builds, and the treatment of a lifetime
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Genentech
Immunocore
Biogen
Eli Lilly
TenSixteen
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
Eleusis, AbbVie/Pfizer/Leo, UCB + Zogenix, Kura, GSK – Unilever
Psychedelic SPACs, eczema frenzy, bio-outs without the biobucks, back on track, and the mega-deal that wasn’t
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Eleusis
Abbvie/Pfizer/Leo
UCB + Zogenix
Kura
GSK – Unilever
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
Scorpion & AstraZeneca, ABL & Sanofi, Vertex, Cochlear, Vaxcyte
Oncology partners, Parkinson’s partners, expanded European Commission, expanded FDA, and bacterial vaccines
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Scorpion & AstraZeneca
ABL & Sanofi
Vertex
Cochlear
Vaxcyte
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
Stryker + Vocera, Merck KGaA + Exelead, BeiGene, Eikon
Devices with tech enablement, nano particles, Chinese approvals, and a massive series B for biotechnology
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Stryker + Vocera
Merck KGaA + Exelead
BeiGene
Eikon
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
Responses